Did you know that men undergo nearly one million UNNECESSARY prostate cancer biopsies each year in the United States? All due to the tragically flawed prostate specific antigen (PSA) test. But [...]
Did you know that men undergo nearly one million UNNECESSARY prostate cancer biopsies each year in the United States? All due to the tragically flawed prostate specific antigen (PSA) test. But [...]
According to a very interesting study, most people (especially men) don’t really enjoy sitting alone…quietly…just thinking. They tend to get caught in negative thought cycles, called [...]
Millions of men in the U.S. suffer from benign prostatic hyperplasia (BPH). This is caused by a benign swelling of the prostate gland, which can obstruct urine flow and make a man’s day-to-day [...]
Prostate cancer is a huge worry for men. And rightly so—as one out of every nine men will be diagnosed with it at some point in their lives. Although, in most cases, these men really have what I [...]
As I started reporting last summer, coronavirus panic caused many patients to put off seeking much-needed medical care. It also caused an almost-complete shutdown of routine cancer screenings for [...]
The mainstream cancer industry spends billions of dollars studying breast cancer. (Even if they are largely barking up the wrong tree.) But research into prostate cancer has been abysmal by [...]
I recently read that the American College of Physicians (ACP) has finally come out against the use of low testosterone drugs—often called “Low-T” drugs—in men. The ACP represents roughly 100,000 [...]
The mainstream cancer research industry treats prostate cancer (and men’s health in general) almost as an afterthought. As I often report, the dreadful prostate specific antigen (PSA) screening [...]
Men’s health issues are underfunded and overlooked by mainstream medicine—especially prostate cancer. In fact, as I’ve written here before, the mainstream still relies on the flawed and outdated [...]
The mainstream can’t stop talking about the new drug lutetium (Lu-177). They’re even calling it a potential “major breakthrough” for metastatic prostate cancer. But I’m quite wary to buy into the [...]